MedTrace Logo

Thrombo-inflammation in Acute Neurovascular Diseases: Definition of New Therapeutic Targets (TARGETS)

NCT07354321 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 499

Last updated 2026-02-05

No results posted yet for this study

Summary

The objective of this observational study is to compare the relative concentrations of various thrombo-inflammatory markers at different follow-up time points in:

* patients with or without delayed cerebral ischemia after subarachnoid hemorrhage, and
* patients with or without rapid progression of necrotic volume after an ischemic stroke due to large- or medium-vessel occlusion in the anterior circulation.

The main question this study aims to answer is: How do thrombo-inflammatory marker concentrations evolve over time and differ between patients? Researchers will compare patients with or without delayed cerebral ischemia after subarachnoid hemorrhage, as well as patients with or without rapid progression of necrotic volume following an ischemic stroke due to large- or medium-vessel occlusion in the anterior circulation, to determine whether there are differences in thrombo-inflammatory marker concentrations and in their evolution over time.

Participants will undergo blood sampling at five different time points. In addition, participants will complete a Montreal Cognitive Assessment (MoCA) questionnaire during the 3-month follow-up visit.

Conditions

  • Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
  • Ischemic Stroke of Large or Medium Vessels

Sponsors & Collaborators

  • François Delvoye

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2032-05-31
Completion
2032-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07354321 on ClinicalTrials.gov